|Publication number||USRE42024 E1|
|Application number||US 11/320,560|
|Publication date||Jan 11, 2011|
|Filing date||Dec 29, 2005|
|Priority date||Nov 12, 1998|
|Publication number||11320560, 320560, US RE42024 E1, US RE42024E1, US-E1-RE42024, USRE42024 E1, USRE42024E1|
|Inventors||Matthew C. Trom, Joel D. Oxman|
|Original Assignee||3M Innovative Properties Company|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (94), Non-Patent Citations (13), Classifications (25), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a continuation-in-part of U.S. patent application Ser. Nos. 09/190,541 now U.S. Pat. No. 6,312,666 and 09/190,717, now U.S. Pat. No. 6,312,667 both filed Nov. 12, 1998, and both of which are incorporated herein by reference in their entireties.
This invention relates to dental compositions having viscosities capable of responding to a change in temperature. The invention also relates to methods of applying the composition directly onto a target area of the substrate.
In the dental art, the use of a dental coating composition is generally desirable for a wide variety of applications, such as etching or bleaching. To attain proper application at the desired location, it is desirable that the composition be controllable and slow to flow away from the target site. Thus a high viscosity dental composition in the oral environment would be quite useful.
Currently available dental compositions are provided in seemingly extreme viscosity states. That is, there exist compositions that have very low viscosities as well as compositions that are highly thickened and therefore possess high viscosity. Those with low viscosities are difficult to control and have tendencies to flow away from the target site once they are applied. Compositions with high viscosities are difficult to extrude through a small orifice.
Certain dental compositions may use thickeners such as fumed silica and polyvinyl alcohols. Problems encountered in using these thickeners include aging, which results in non-homogenous gels which make handling difficult, and shear thinning, which reduces the viscosity of a gel when extruded through an orifice and thinning at elevated temperatures. Thinning can result in a material that drips from the orifice and that may fail to remain localized at the desired point of application.
The present invention provides a dental composition suitable for application in the oral environment comprising a thermally responsive viscosity modifier that is capable of undergoing an increase in viscosity in response to an increase in temperature. These compositions also preferably have the ability to reverse their viscosity upon the lowering of temperature.
Compositions of the invention work very well in the oral environment where temperature is generally higher than ambient or the pre-treatment temperature of a composition. This differential in temperature thickens the composition and thus provides a thickened, semi-solid or gel-like composition in the oral environment.
A preferred method of use of the invention comprises applying the composition directly onto the oral surface. Upon exposure of the composition to the oral temperature, the composition thickens to a semi-solid or gel-like state.
In one aspect, the present invention provides a method of applying a dental composition in the oral environment using a dental composition comprising about 10% by weight to about 50% by weight of a thermally responsive viscosity modifier and an adjuvant, wherein the composition is in a low viscosity state at a pre-treatment temperature and a highly viscous state at a treatment temperature that is higher than the pre-treatment temperature. The method includes applying the composition through an orifice, preferably the orifice of a syringe, onto a surface, wherein the composition is at the pretreatment temperature and in the low viscosity state prior to being applied onto the surface, allowing the composition to warm to the treatment temperature and increase in viscosity to the highly viscous state wherein the viscosity of the composition at the treatment temperature is at least about 10 times the viscosity of the composition at the pre-treatment temperature, and allowing the composition to remain on the surface. Preferably the pre-treatment temperature is at most about room temperature and the treatment temperature is about body temperature. Preferred adjuvants include acids, whitening agents, fluoride, anti-microbial agents, and medicaments.
The present invention provides a dental composition in a low viscosity state prior to application onto an oral surface, but which also is highly viscous, thick and controllable at the target site. These compositions are easily dispensed, applied, and manipulated when handled by the user, and are easily controlled upon application to the target site. Because the composition has a low viscosity initially at a pre-treatment temperature, it requires lower syringe extrusion forces to deliver the compositions to the intended site. In turn, this would allow a user the alternative of using a brush or other applicator to apply the composition. In addition, production of low viscosity compositions may provide easier processing and greater uniformity and consistency.
Compositions of this invention are particularly suitable for use in the intraoral environment where a composition having a pre-treatment temperature at or lower than ambient (room temperature) is applied to a user's oral surface that is near or at oral temperature of about 30° C. to about 39° C. For certain dental applications, it is preferred that the composition be thermally reversible. In that application, the composition not only has the ability to increase its viscosity at an elevated intra-oral temperature, but also reverses or decreases its viscosity upon a decrease in temperature.
The capacity of the dental composition to thicken at oral temperatures is a critical feature of the invention, for it is in this property that many of the disadvantages of previous approaches are overcome. The dissipative characteristic of liquid solutions is avoided since the compositions herein experience thickening at the site of treatment. Moreover, the problems of formulation, handling, delivery and application of viscous compositions are overcome since the present compositions may be free-flowing liquids prior to treatment.
For example, the art of etching hard tissue typically requires etching a target site or controlled areas of several teeth at one time. Current etchant liquids are easy to dispense and apply, but these tend to flow away from the target area of application. Consequently, an etch patch could be larger than desired or, more undesirably, contact with the soft tissue could occur, which can cause sensitivity or irritation. A large etch patch unnecessarily increases the risk of decalcification during treatment. Some compositions have been provided in thickened states to provide less flow and mobility; however, they are often difficult to dispense.
Furthermore, other applications, such as dental whitening, suffer when the dental whitening compositions decrease in viscosity due to the increase in temperature from the intraoral environment. This thinning and viscosity decrease creates a tendency for the whitening composition to flow from the target location, resulting in a reduced amount of whitening composition available for treatment at the target location for the desired length of time.
A “semi-solid,” as used herein, is a material whose physical state is between the solid and liquid state, in which pure or mixed solvent or solution is entrained within a network, and can alternatively be considered a gel. By “pure or mixed solvent and/or solution,” as stated herein, it is recognized that a mixture of solvents may be absorbed by the network. Additionally, the solvent may include salts or other additives so as to form a solution, which may also be absorbed or entrained within the network.
“Thickening” as used herein, is where a composition undergoes a substantial increase in the viscosity of the composition. The degree of thickening is dependent on the initial viscosity of the composition.
In a preferred embodiment of the invention, the initial viscosity of the composition may be low enough such that the composition is in a liquid state. Subsequently, upon exposure to a temperature of about near or at oral temperature, the viscosity increases to result in a thickened composition. A viscosity increase in the range of about 10- to about 100-fold can be experienced when the initial viscosity is such that the composition is a liquid. Thus, for example, a composition in a liquid state may have a viscosity of about 0 to about 7000 poise. In response to an increase in temperature, the viscosity of the composition can increase to at least about 10,000 poise. Upon the lowering of the temperature, the composition preferably has the ability to reverse its viscosity and return to flow properties of a liquid.
Yet another preferred embodiment of the invention is when the initial viscosity of the composition is at a level at which the composition is in a semi-solid state at pre-treatment temperature (viscosity is at least about 5000 poise), and upon exposure to a higher treatment temperature, the composition transforms into an “ultra-thick” composition or one with a substantially higher viscosity and very low flow characteristics. For compositions having initially high viscosities, the degree of thickening is typically about 2- to about 5-fold.
The pre-treatment temperature is the temperature at which the composition is subjected to prior to application or treatment. The range for the pre-treatment temperature can be about 5° C. to about 29° C., although there may be certain instances where the temperature may be outside this range. Having a pre-treatment temperature at about 20° C. to about 25° C. allows the composition to be easily stored at ambient or room temperature. Alternatively, the compositions of the invention can also be advantageously stored at lower, refrigeration pre-treatment temperatures of about 5° C. to about 10° C. to provide improved stability and shelf life.
The treatment temperature is the temperature at which the composition is exposed during intraoral application. This can be at or near body temperature, or about 30° C. to about 39° C.
In accordance with the invention, the dental composition consists of a water-miscible, physiologically compatible medium that is liquid at ambient temperature below about 30° C. and experiences thickening at oral temperatures above about 30° C. It has been found that a composition having a thickening transition temperature in the range of from about 25° C. to about 40° C. is useful in the practice of the present invention. Preferably, the thickening occurs in a temperature range of from about 25° C. to about 39° C., and more preferably from about 30° C. to about 35° C.
Compositions of this invention are comprised of a solvent and one or more polymeric substances that provide the desired viscosity increase at the desired elevated temperature range in the said composition. Optionally, adjuvants may be added to the composition. Preferably, the composition of this invention should be physiologically compatible so that no adverse reaction occurs if the dental composition comes in contact with human tissue or fluids.
As used herein, a “thermally responsive viscosity modifier” is one or more polymeric substances that provide the composition or polymeric system the capability of substantially changing its viscosity in response to a change in temperature. Suitable polymeric substances useful as thermally responsive viscosity modifiers include polyoxyalkylene polymers, particularly the polymeric surfactants available under the tradename PLURONIC. This class of polymers is available commercially from BASF Wyandotte Corporation. Other polyoxyalkylene polymers may also be useful as a thermally-responsive composition material.
A preferred dental composition in accordance with this invention comprises an aqueous solution of a selected polyoxyethylene-polyoxypropylene block copolymer. A composition comprising polyoxyethylene-polyoxypropylene block copolymers in which the number of polyoxyethylene units is at least about 50% of the number of units in the total molecule, and the block copolymer having an average molecular weight of from about 1100 to about 15,500 has been found to be particularly useful. It is more preferable that a composition comprises about 70% polyoxyethylene units of the total number of monomeric units in the copolymer and the copolymer has an average molecular weight of about 11,500. PLURONIC F-127 is a material that meets these criteria.
The PLURONIC polymers are closely related block copolymers that may be generically classified as polyoxypropylene-polyoxyethylene condensates that terminate in primary hydroxyl groups. These polymers are formed by the condensation of propylene oxide into a propylene glycol nucleus followed by the condensation of ethylene oxide onto both ends of the polyoxypropylene base. The polyoxyethylene hydrophilic groups on the ends of the base pre-polymer are controlled in length to constitute from about 10% to about 80% by weight of the final polymer.
The PLURONIC polymer series of products may be represented empirically by the formula: HO(C2H4O)a(C3H6O)b(C2H4O)cH where a and c are statistically equal.
The concentration of the block copolymers is an important parameter and can be formulated in such a manner corresponding to the other components' concentrations. By adjusting the concentration of the copolymer to accommodate other solutes present in the composition, any desired liquid to semi-solid transition temperature in the critical range of above ambient temperature and below body temperature can be achieved. Thus, the principal consideration is the selection of a concentration that, in conjunction with all of the constituents of the total composition, will provide a liquid to semi-solid transition temperature in the required range.
It has been found that a useful block copolymer concentration is from about 5% to about 40% by weight (wt. %) of the composition, particularly from about 15 wt. % to about 26 wt. % of the composition. Excellent results have been obtained using aqueous solutions having from about 17 wt. % to about 29 wt. % of PLURON1C F-127. Increased polymer concentrations may be required in highly acidic systems to affect the same results as in a less acidic system so that, in optimizing the thickening or gelation characteristics for a system, the pH of the solution must be taken into account.
Particularly preferred polymers for the present invention are the PLURONIC F-127 and F-108. These viscosity modifiers are block copolymers of ethylene oxide and propylene oxide. Thickening tendencies of block copolymers increase as ethylene oxide content and total molecular weight increase. Thermally responsive block copolymers have been disclosed in U.S. Pat. Nos. 4,474,751; 4,474,752; 5,441,732; and 5,252,318, as well as the Product Catalog, “BASF Performance Chemicals,” all the teachings of which are incorporated by reference herein. These block copolymers offer extremely low toxicity and a high degree of mildness for applications involving human contact.
A preferred solvent for the composition of this invention is water. The concentration of water in the composition can be in the range of from about 30 wt. % to about 90 wt. % of the composition. Preferably, water can exist in the range of about 40 wt. % to about 80 wt. % of the composition. The water used in forming the aqueous solution is preferably purified, as by distillation, filtration, ion-exchange, or the like.
Co-solvents may be used, including anhydrous solutions comprising a polyol component such as propylene glycol or polyethylene glycol. Glycerin may also be used as a constituent of the composition.
Adjuvants can be added to the composition for various purposes (e.g., acids for dental etchants and whitening agents for dental whiteners). For example, a preferred embodiment of the invention can contain fluoride, a desirable additive in the oral composition. Additives may also be included in the composition to promote the stability of the formulation. Anti-microbial agents, anti-fungal agents, and preservatives may be added to the composition to improve shelf-life. The compositions may further include other adjuvants such as medicaments, indicators, dyes, wetting agents, buffering agents, thixotropes, polyols and the like, contingent upon attainment of the desired degree of etching performance and suitability for use on the desired hard tissue. For example, a composition may contain indicators that communicate to the user the degree of etching that has been performed on the hard tissue. The compositions may further include other adjuvants such as fillers, cariostatic agents and flavorings.
When the dental composition is a dental etchant, acids may be added to the composition as an adjuvant. Acids for use in the present invention can be inorganic or organic acids, and if organic can be monomeric, oligomeric or polymeric. If desired, a precursor to the acid such as an acid anhydride, e.g., 4-Methacryloxyethyl Trimellitate Anhydride (4-META), acid halide (including inorganic acid halides such as Lewis acids, e.g., ferric chloride, and organic acid halides), or ester can be used in place of the acid itself, e.g., to generate the desired acid in situ. Suitable acids include mineral acids, carboxylic acids, sulfonic acids, and phenols, with carboxylic acids, alkylsulfonic acids, arylsulfonic acids, and phosphonic acids being preferred.
The acid has a pKa in water that is less than or equal to that of phenol. Preferably, the pKa of the acid is between about −20 and about +10, more preferably between about −10 and about +5.
The acid can be liquid or a solid; if a solid it should be dissolved in a suitable solvent to enable the acid to wet the hard tissue. Liquid acids can also be dissolved in a suitable solvent, e.g., in order to facilitate wetting. Preferred solvents for the acid are the film former cosolvents discussed in more detail below.
Suitable inorganic acids include hydrobromic acid, hydrochloric acid, nitric acid, phosphoric acid, and sulfuric acid. Suitable organic acids include acetic acid, α-chloropropionic acid, 2-acrylamido-2-methylpropane sulfonic acid, acrylic acid, benzenesulfonic acid, benzoic acid, bromoacetic acid, 10-camphorquinone-sulfonic acid, 10-camphorsulfonic acid, chloroacetic acid, citraconic acid, citric acid, dibromoacetic acid, dichloroacetic acid, di-Hema ester of 1,2,4,5 benzenetetracarboxylic acid, 2,4-dinitrophenol, ethylenediaminetetraacetic acid (EDTA), the mono-, di- and trivalent salts of EDTA, formic acid, fumaric acid, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, maleic acid, methacrylic acid, 2-naphthalene sulfonic acid, oxalic acid, p-nitrophenol, phenol, phosphorous acid esters (such as 2,2′-bis(a-methacryloxy-b-hydroxypropoxyphenyl) propane diphosphonate (Bis-GMA diphosphonate), dibutyl phosphite, di-2-ethyl-hexyl phosphate, di-2-ethyl-hexyl phosphite, hydroxyethyl methacrylate monophosphate, glyceryl dimethacrylate phosphate, glyceryl-2-phosphate, glycerylphosphoric acid, methacryloxyethyl phosphate, pentaerythritol triacrylate monophosphate, pentaerythritol trimethacrylate monophosphate, dipentaerythritol pentaacrylate monophosphate, and dipentaerythritol pentamethacrylate monophosphate), pivalic acid, propionic acid, toluene sulfonic acid, tribromoacetic acid, trichloroacetic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, and trihydroxybenzoic acid. Mixtures of such acids can be used if desired.
In the practice of the present invention, the hard tissues that can be etched include human and animal tissues such as teeth, including the component parts which are enamel, dentin, and cementum. The invention has particular utility for etching dentin, sclerotic dentin, enamel, and cervical enamel. In a preferred method of the invention, the etchant is permitted to stand on the hard tissue for a desired period of time, readily volatile cosolvents are removed therefrom (e.g., by air-drying) to modify the surface of the hard tissue. Delivery of the etching composition of the invention may be performed in various methods. One method of delivery of the etching composition is the direct application of the composition onto the hard tissue. This may be done directly from the composition's container or dispenser such as a bottle, vial, syringe, or tube. Alternatively, it can be applied by using a brush to paint or coat the composition onto the hard tissue. The composition is kept on the hard tissue for a desired period to effectuate etching. The length of time the composition is in contact with the hard tissue would depend on the amount of etching desired.
A preferred method of use comprises first etching with the composition of the present invention, followed by an application of a dental material on the tissue such as a sealant or coating, restorative material, adhesive, cement, dental primer or film former. Yet another preferred method is first etching with the composition of the present invention, then followed by an application of a bonding agent for purposes of bonding an orthodontic appliance onto a tooth. The invention enables etching of hard tissue in order to improve the bond strength or durability of a restorative or coating applied thereto.
Hard tissue to which the etchant is applied preferably is first cleaned using conventional methods (e.g., by abrading it with a bur), rinsed (e.g., using water) and dried (e.g., using air). If desired, deep excavations in teeth can be lined with a conventional basing material, (e.g., calcium hydroxide or a glass ionomer cement).
The acid should be allowed to stand on the surface of the hard tissue long enough to provide the desired degree of etching. The standing time will depend upon the particular acid employed, the type of hard tissue and its intended use, and the time available for carrying out the etching procedure. For etching dentin and enamel, standing times less than about 5 minutes, and preferably about 5 seconds to one minute provide very effective etching, although shorter or longer times can be used if desired.
When the dental composition is a dental whitener, whitening agents may be added to the composition as an adjuvant. The whitening agent used in the present invention may be any material that has the effect of whitening teeth. Whitening agents are preferably selected from hydrogen peroxide and its urea complex: carbamide peroxide (CO (NH2)2H2O2). These whitening agents are also known by alternative names, including urea hydrogen peroxide, hydrogen peroxide carbamide, or perhydrol-urea. Alternatively, sodium hypochlorite may be suitable for use as the whitening agent. The concentration of a whitening agent in the composition can vary depending upon its reactivity. With carbamide peroxide, for example, the currently preferred concentration range is from about 3% to about 40%, with a range from about 4% to about 21% being most preferred. In the case of hydrogen peroxide, which is more reactive than carbamide peroxide, the currently preferred concentration range is from about 2% to about 10%.
Various methods can be employed in using the whitening composition of this invention. One method of use of these whitening compositions entails application of the composition to the tooth structure directly from the composition's container or dispenser such as a bottle, syringe, or tube. Alternatively, the whitening composition can be applied by using a brush to paint it onto the tooth surface. The composition is kept on the user's tooth surface(s) for a desired time period to effectuate whitening. The length of time the composition is in contact with the tooth surface(s) would depend on the amount of discoloration the user prefers to remove.
In a preferred method, the whitening composition is loaded into a dental tray. Such dental trays can be custom fitted to a user's dentition and be made with or without reservoirs. A preferred reservoir is described in U.S. Pat. No. 6,126,443. Dental trays can be made from varying thicknesses and softness of pliable thermo-formable plastic materials. Typically, these materials are 0.02-0.08 inches thick. After dispensing or loading the whitening composition into the dental tray, the user then places the loaded tray into the mouth and initiates thickening of the composition. The thickening occurs when the composition is exposed to the elevated treatment temperature of the oral environment. The tray is retained in the mouth to effectuate whitening of the tooth surface(s) for a sufficient period of time to remove discoloration.
An alternative method of use incorporates a pre-warmed dental tray into which the whitening composition is loaded. Upon contact of the composition having a pre-treatment temperature, with the tray having a higher temperature, the composition experiences thickening. This method provides easy handling of a loaded tray into a user's mouth, with minimal fear of the composition moving to an undesired section of the tray or having the composition flow out of the tray. Where the dental compositions are thermally reversible, the composition can be readily removed from the hard tissue by cooling the material below the liquid to semi-solid transition temperature, thus reversing the thickening effect. This can be accomplished with cool water or other physiologically compatible liquid. Alternatively, the concentrations of the components in the composition may be adjusted and diluted by adding water or other liquid solution. By adjusting the concentrations of the components, the transition temperature is correspondingly adjusted, and thus provides the user the ability to remove the composition even with warm solutions. Water or other liquid solutions may be administered through a rinsing cup, squirt bottle, a liquid dispensing dental tool, or any other liquid dispensing device that can provide solution to the oral environment. Preferably, administering cool or cold water provides a significant decrease in viscosity. Alternatively, the composition may be brushed, wiped, or blown off.
These and other aspects of the invention are illustrated by the following examples that should not be viewed as limiting in scope. Unless otherwise indicated, all molecular weights are number average molecular weights and all ratios, parts and percentages are by weight.
Etching compositions were made in which the acid used was 3M Etchant Liquid manufactured by 3M Dental Products Division. Sample compositions 2 through 7 were mixed such that the compositions contained 15-30% by weight of PLURONIC F127 (BASF) in 3M Etchant Liquid (3M Co., St. Paul, Minn.).
Complex viscosity versus temperature data were obtained using a controlled strain rheometer (“RDA2”, Rheometrics Scientific, Piscataway, N.J.). A parallel plate geometry was used with a plate diameter of 25 mm and a gap of approximately 1 mm. Samples were subjected to an oscillatory strain of 10% applied at a frequency of 1 rad/sec while the temperature was ramped from 15° to 45° C. (3° C./min). The resulting data is shown in FIG. 1.
The compositions 1-7 are phosphoric acid gels of the following types:
Compositions 2 and 7 were further tested using a laboratory convection oven, heated to a temperature of approximately 45° C.
The concentration of PLURON1C F127 had significant impact on the initial viscosity of the acid etchant gel as well as the temperature at which the acid formed an “immobile gel.” An “immobile gel” indicates that the gel did not flow readily under its own weight in small volumes but was still able to be easily manipulated into new positions using hand-held dental instruments. The composition that contained 15.3% PLURONIC F127 had a low initial viscosity similar to that of 3M Etchant Liquid and did not form an immobile gel at approximately body temperature but did form an immobile gel at approximately 45° C. The composition containing 28.8% PLURONIC F127 was a thick liquid when cooled in a refrigerator at approximately 5° C., but was an immobile gel at room temperature of approximately 24° C.
An acid composition (gel) containing 24% PLURONIC F127 and 76% 3M Etchant Liquid was placed on a bovine tooth heated to 37° C. The gel was extruded from a syringe as a liquid but formed an immobile gel on contact with the tooth. The gel was left in place for 30 seconds, washed with cold water and dried in the air. There was an obvious difference between the etched and unetched surfaces indicating that the acid gel was effective.
An acid gel containing 19.4% PLURONIC F127, 8.1% citric acid (Aldrich, Milwaukee, Wis.) and 72.5% DI water was placed on a bovine tooth heated to 37° C. The gel was extruded from a bottle as a liquid but formed an immobile gel on contact with the tooth. The gel was left in place for 45 seconds, washed with cold water and air dried. There was an obvious difference between the etched and unetched surfaces indicating that the acid gel was effective.
The citric acid and phosphoric acid gels had similar initial viscosity and gel characteristics with significantly different levels of PLURONIC F127. More PLURONIC F127 is required in highly acidic systems to affect the same results as in a less acidic system so that, in optimizing the gelation characteristics for a system, pH of the stock etchant solution must be taken into account.
Preparation of Stock Solution 1
An aqueous stock solution containing approximately 15% hydrogen peroxide (H2O2) was prepared by transferring 5 grams of a 30% H2O2 (J. T. Baker) and 5 grams of distilled water to a glass vial. The stock solution was mixed thoroughly.
Preparation of Stock Solution 2
An aqueous stock solution containing approximately 20% urea hydrogen peroxide (carbamide peroxide) was prepared by transferring 4 grams of 97% urea hydrogen peroxide (Sigma) and 16 grams of distilled water to a glass vial. The stock solution was mixed thoroughly. (The hydrogen peroxide content of the urea hydrogen peroxide was about 35%). Stock solution contained about 7% H2O2.
A thermally-reversible hydrogen peroxide composition was prepared by transferring the ingredients below to a glass vial and mixing thoroughly until a colorless and transparent liquid solution was obtained.
Stock Solution 1 1.60 grams PLURONIC F127 (BASF) 0.40 grams 2.00 grams
The above solution contained approximately 12% hydrogen peroxide, 68% water and 20% PLURONIC F127. The glass vial containing the liquid peroxide solution was warmed to body temperature by holding the vial in a human hand. Following about one to two minutes, the liquid was transformed into a colorless, transparent composition that did not flow upon inverting the vial. The vial was allowed to cool to room temperature wherein the composition was transformed back to the low viscosity state. This cycle was repeated several limes with the same outcome.
The liquid and semi-solid (gel) states were both semi-quantitatively evaluated for hydrogen peroxide utilizing hydrogen peroxide analysis strips. The analysis utilized “EM Quant Peroxide Test Strips” (EM Science Gibbstown, N.J., Catalog No. 10011-1). The compositions were evaluated according to the manufacturer's directions.
Results of the tests indicated that both the liquid and semi-solid states contained significant amounts of available peroxide.
The same sample was re-evaluated 2 months later and found to still exhibit thermally-reversible characteristics and comparable hydrogen peroxide levels based on the semi-quantitative analysis.
A thermally reversible composition containing urea hydrogen peroxide was prepared by transferring the ingredients below to a glass vial and mixing thoroughly until a colorless and transparent liquid solution was obtained.
Stock Solution 2 4.00 grams PLURONIC F127 (BASF) 1.00 grams 5.00 grams
The above solution contained approximately 16% urea hydrogen peroxide (or about 5.6% hydrogen peroxide), 64% water and 20% PLURONIC F127. The glass vial containing the liquid peroxide solution was warmed to body temperature by holding the vial in a human hand. After about 1 minute, the liquid transformed to a colorless, transparent composition that did not flow upon inverting the vial. The vial was allowed to cool to room temperature wherein the semi-solid composition was transformed back to the low viscosity state. This cycle was repeated several times with the same outcome.
The liquid and semi-solid states were both semi-quantitatively evaluated for hydrogen peroxide utilizing hydrogen peroxide analysis strips, EM Quant Peroxide Test Strips (EM Science; Gibbstown, N.J., Catalog No. 10011-1), according to the manufacturer's directions. Both the liquid and semi-solid states indicated the presence of significant amounts of available peroxide.
The same sample was re-evaluated 9 days later and found to still exhibit thermally-reversible characteristics and comparable hydrogen peroxide levels based on the semi-quantitative analysis.
Table 1 summarizes the results of the two previous examples. The “+” indicates an increase in the viscosity. The indicates a decrease in the viscosity. The presence of hydrogen peroxide as indicated in the table are the results obtained from the semi-quantitative test using the EM Quant Peroxide Test Strips and test method.
@ 9 days
@ 9 days
Several compositions have been evaluated for viscosity as a function of temperature. The compositions are described below:
Comparative Sample A
at 23° C.
at body temp
*available from Cabot Corp. (Boston, MA)
Samples were further evaluated for viscosity as a function of temperature between 15° C. and 45° C. utilizing a Rheometrics RDA II Rheometer. Complex viscosity, η* (units of measure is in Poise), versus temperature data were obtained using a controlled strain rheometer (“RDA2”, Rheometrics Scientific, Piscataway, N.J.). A parallel plate geometry was used with a plate diameter of 25 mm and a gap of approximately 1 mm. Samples were subjected to an oscillatory strain of 10% applied at a frequency of 1 rad/sec while the temperature was ramped from 15° C. and 45° C. (3° C./min).
Set out below is the RDA viscosity data.
1.04E + 05
1.09E + 05
1.13E + 05
1.20E + 05
1.26E + 05
1.32E + 05
1.36E + 05
1.39E + 05
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3639574||Oct 25, 1967||Feb 1, 1972||Basf Wyandotte Corp||Stable hydrogen peroxide gels|
|US3652420||May 27, 1968||Mar 28, 1972||Peter Strong & Co Inc||Cleanser compositons for artificial dentures and methods of preparing the same|
|US4011309||Jan 14, 1976||Mar 8, 1977||Marion Laboratories, Inc.||Dentifrice composition and method for desensitizing sensitive teeth|
|US4100271||Feb 26, 1976||Jul 11, 1978||Cooper Laboratories, Inc.||Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes|
|US4130501||Sep 20, 1976||Dec 19, 1978||Fmc Corporation||Stable viscous hydrogen peroxide solutions containing a surfactant and a method of preparing the same|
|US4188373||Nov 18, 1977||Feb 12, 1980||Cooper Laboratories, Inc.||Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes|
|US4260597 *||Sep 4, 1979||Apr 7, 1981||Porteous Don D||Thermally reversible dental astringent gels|
|US4474751||May 16, 1983||Oct 2, 1984||Merck & Co., Inc.||Ophthalmic drug delivery system utilizing thermosetting gels|
|US4474752||May 16, 1983||Oct 2, 1984||Merck & Co., Inc.||Drug delivery system utilizing thermosetting gels|
|US4537778||Feb 13, 1984||Aug 27, 1985||Colgate-Palmolive Company||Oral preparation|
|US4696757||Jun 16, 1986||Sep 29, 1987||American Home Products Corporation||Stable hydrogen peroxide gels|
|US4719149||Feb 28, 1986||Jan 12, 1988||Minnesota Mining And Manufacturing Company||Method for priming hard tissue|
|US4770634||Jun 11, 1986||Sep 13, 1988||Pellico Michael A||Method for treating teeth with foamable fluoride compositions|
|US4774093||Jun 25, 1985||Sep 27, 1988||Fmc Corporation||Polysaccharide compositions, preparation and uses|
|US4795527||Dec 7, 1987||Jan 3, 1989||Howard Cohen||Tooth etching|
|US4839156||Apr 17, 1987||Jun 13, 1989||Colgate-Palmolive Company||Stable hydrogen peroxide dental gel|
|US4861760||Sep 25, 1986||Aug 29, 1989||Merck & Co., Inc.||Ophthalmological composition of the type which undergoes liquid-gel phase transition|
|US4888168||Dec 2, 1987||Dec 19, 1989||American Cyanamid Company||Stable ophthalmic preparations containing acetazolamide|
|US4921626||Aug 23, 1989||May 1, 1990||Automark Corporation||Glass etching composition and method of making|
|US4980152||Aug 6, 1987||Dec 25, 1990||Marion Laboratories||Oral preparation|
|US5000955||Jul 23, 1990||Mar 19, 1991||Tyndale Plains-Hunter Ltd.||Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses|
|US5057308||Jun 8, 1990||Oct 15, 1991||Hill Ira D||Method of treating the oral cavity with oral hygiene preparations containing active SnF2|
|US5057309||Jun 8, 1990||Oct 15, 1991||Hill Ira D||Oral hygiene preparations|
|US5057310||Jun 8, 1990||Oct 15, 1991||Hill Ira D||Method of manufacturing oral hygiene preparations containing active SnF.sub.|
|US5059417||Jun 26, 1990||Oct 22, 1991||Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.||Peroxide gel dentifrice|
|US5061183||Nov 13, 1989||Oct 29, 1991||Nicholson James A||Acid etch for bonding ceramic orthodontic brackets|
|US5071637||Oct 6, 1989||Dec 10, 1991||Pellico Michael A||Foamable fluoride compositions and method|
|US5073363||Jan 16, 1990||Dec 17, 1991||Pellico Michael A||Foamable fluoride gels and method|
|US5077033||Aug 7, 1990||Dec 31, 1991||Mediventures Inc.||Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide|
|US5078129||Mar 8, 1990||Jan 7, 1992||Research Foundation Of State University Of New York||Device for stimulating salivation|
|US5098303||Jul 13, 1990||Mar 24, 1992||Ultradent Products, Inc.||Method for bleaching teeth|
|US5122365||Feb 15, 1989||Jun 16, 1992||Natural White, Inc.||Teeth whitener|
|US5124151||Aug 7, 1990||Jun 23, 1992||Mediventures Inc.||Drug delivery by injection with thermo-irreversible gels|
|US5171564||Sep 13, 1991||Dec 15, 1992||Colgate-Palmolive||Aqueous tooth whitening dentifrice|
|US5234342||Jun 20, 1991||Aug 10, 1993||Ultradent Products, Inc.||Sustained release method for treating teeth surfaces|
|US5252318||Jun 15, 1990||Oct 12, 1993||Allergan, Inc.||Reversible gelation compositions and methods of use|
|US5256065||Oct 29, 1991||Oct 26, 1993||Nicholson James A||Acid etch for dental treatments|
|US5256396||Jan 24, 1990||Oct 26, 1993||Colgate-Palmolive Company||Topical composition|
|US5300295||Sep 13, 1991||Apr 5, 1994||Mediventures, Inc.||Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH|
|US5340613||Mar 12, 1993||Aug 23, 1994||Minnesota Mining And Manufacturing Company||Process for simultaneously coating multiple layers of thermoreversible organogels and coated articles produced thereby|
|US5376006||Sep 24, 1992||Dec 27, 1994||Ultradent Products, Inc.||Dental bleaching compositions and methods for bleaching teeth surfaces|
|US5376693||Oct 26, 1990||Dec 27, 1994||Mediventures Inc.||Thermo-irreversible gel corneal contact lens formed in situ|
|US5376695||Apr 14, 1992||Dec 27, 1994||Thor Chemie Gmbh||Stabilized aqueous solutions of 3-isothiazolones|
|US5378542||Jun 6, 1994||Jan 3, 1995||Minnesota Mining And Manufacturing Company||Process for simultaneously coating multiple layers of thermoreversible organogels and coated articles produced thereby|
|US5401495||Aug 20, 1991||Mar 28, 1995||Natural White, Inc.||Teeth whitener|
|US5409630||Feb 3, 1994||Apr 25, 1995||Colgate Palmolive Co.||Thickened stable acidic microemulsion cleaning composition|
|US5409631||Nov 22, 1991||Apr 25, 1995||Ultradent Products||Dental bleaching compositions and methods for bleaching teeth surfaces|
|US5441732||Mar 18, 1992||Aug 15, 1995||Allergan, Inc.||Reversible gelation emulsion compositions and methods of use|
|US5492937||Oct 30, 1991||Feb 20, 1996||Pharmacia Ab||Gel-forming liquid carrier composition|
|US5575652||May 18, 1995||Nov 19, 1996||Colgate Palmolive Company||Process for applying antibacterial oral composition to dental implant areas|
|US5631000||Mar 11, 1996||May 20, 1997||Laclede Professional Products, Inc.||Anhydrous tooth whitening gel|
|US5718886||Dec 23, 1996||Feb 17, 1998||Laclede Professional Products, Inc.||Stabilized anhydrous tooth whitening gel|
|US5725843||Sep 27, 1996||Mar 10, 1998||Ultradent Products, Inc.||Methods for bleaching teeth surfaces|
|US5746598||Sep 27, 1996||May 5, 1998||Ultradent Products, Inc.||Dental bleaching compositions including a sticky matrix material|
|US5766012||Apr 28, 1997||Jun 16, 1998||Rosenbaum; Michael||Dental etchant and process of using|
|US5766574||Nov 15, 1996||Jun 16, 1998||Colgate Palmolive Company||Dual component tooth whitening dentifrice|
|US5770105||Sep 30, 1996||Jun 23, 1998||Ultradent Products, Inc.||Methods for manufacturing sticky bleaching compositions|
|US5814304||Jul 10, 1997||Sep 29, 1998||Colgate Palmolive Company||Stable aqueous abrasive peroxide tooth whitening dentifrice|
|US5819988||Apr 1, 1997||Oct 13, 1998||Sawhney; Ravi K.||Double-barreled syringe with detachable locking mixing tip|
|US5846570||Jun 27, 1997||Dec 8, 1998||Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.||Stabilized hydrogen peroxide gel compositions|
|US5847023||Nov 3, 1995||Dec 8, 1998||Mdv Technologies, Inc.||Thermal irreversible gel corneal contact lens formed in situ|
|US5851514||Aug 2, 1996||Dec 22, 1998||Colgate Palmolive Company||Stable aqueous abrasive peroxide tooth whitening dentifrice|
|US5861148||Dec 12, 1996||Jan 19, 1999||Smith; Stewart Gregory||Ophthalmic compositions and process of using|
|US5902568||Nov 26, 1997||May 11, 1999||Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.||Method for whitening teeth|
|US5915967||Nov 14, 1994||Jun 29, 1999||Mcgill University||Implant assembly|
|US5928628||Oct 23, 1997||Jul 27, 1999||Pellico; Michael A.||Two-component dental bleaching system and method|
|US6116900||Nov 12, 1998||Sep 12, 2000||Lumachem, Inc.||Binary energizer and peroxide delivery system for dental bleaching|
|US6126443||Dec 21, 1998||Oct 3, 2000||3M Innovative Properties Company||Medication delivery tray|
|US6312666||Nov 12, 1998||Nov 6, 2001||3M Innovative Properties Company||Methods of whitening teeth|
|US6312667||Nov 12, 1998||Nov 6, 2001||3M Innovative Properties Company||Methods of etching hard tissue in the oral environment|
|EP0102200A2||Aug 1, 1983||Mar 7, 1984||JOHNSON & JOHNSON DENTAL PRODUCTS COMPANY||Neutral topical sodium fluoride gel|
|EP0288420B1||Apr 15, 1988||Dec 30, 1992||Colgate-Palmolive Company||Stable hydrogen peroxide dental gel|
|EP0325267B1||Jan 20, 1989||May 11, 1994||Carter-Wallace Inc.||Peroxide gel dentifrice compositions|
|EP0535816A2||Sep 11, 1992||Apr 7, 1993||Colgate-Palmolive Company||Abrasive tooth whitening dentifrice of improved stability|
|EP0545594B1||Nov 20, 1992||May 1, 1996||Colgate-Palmolive Company||Oral composition having improved tooth whitening effect|
|EP0551626A1 *||Dec 16, 1992||Jul 21, 1993||LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d.||Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation|
|EP0612512A2||Feb 25, 1987||Aug 31, 1994||Minnesota Mining And Manufacturing Company||Use of a composition for the manufacture of a primer for coating dentin|
|EP0758544A2||Aug 9, 1996||Feb 19, 1997||Sun Medical Co., Ltd.||Dental or surgical adhesive and polymerization initiator composition for the same|
|GB1571832A||Title not available|
|GB2170406A||Title not available|
|JPS59128330A||Title not available|
|WO1986000813A1||Jul 18, 1985||Feb 13, 1986||Schering Ag||Pharmaceutical compositions containing gels|
|WO1991014650A1||Mar 18, 1991||Oct 3, 1991||Ultradent Products Inc||Dental compositions and methods for treating teeth surfaces|
|WO1995013028A1||Nov 14, 1994||May 18, 1995||Cameron Malcolm Lang Clokie||Implant assembly|
|WO1996002577A1||Jul 18, 1995||Feb 1, 1996||Gel Sciences Inc||Responsive polymer gel beads|
|WO1996006134A1||Aug 21, 1995||Feb 29, 1996||Gel Sciences Inc||Responsive gels for selective removal of a target from an environment and methods therefor|
|WO1996025457A1||Feb 16, 1996||Aug 22, 1996||Gel Sciences Inc||Gel network containing a reactive material|
|WO1996028056A1||Mar 15, 1996||Sep 19, 1996||Gel Sciences Inc||Conformable structures|
|WO1997000275A2||Jun 14, 1996||Jan 3, 1997||Lev Bromberg||Responsive polymer networks and methods of their use|
|WO1997002276A2||Title not available|
|WO1997011675A1||Sep 24, 1996||Apr 3, 1997||Colgate Palmolive Co||Stable aqueous abrasive peroxide tooth whitening dentifrice|
|WO1998030494A1||Oct 10, 1997||Jul 16, 1998||Ultradent Products Inc||Dental bleaching compositions with high concentration of hydrogen peroxide|
|WO2000028946A1||Mar 9, 1999||May 25, 2000||Minnesota Mining & Mfg||Dental etching composition|
|WO2000028955A1||Mar 16, 1999||May 25, 2000||Minnesota Mining & Mfg||Dental whitening composition|
|1||"Buyer's Guide to Whitening Systems," Dentistry Today, pp. 125-134 (Dec. 1997).|
|2||"Discuss Dental product information sheets for Professional Whitening Products," [on-line]. Discuss Dental [retrieved on Mar. 13, 2000]. Retrieved from the Internet: ;13 pgs.|
|3||"Surfactants, Pluronic & Tetronic," BASF product information brochure, Mount Olive, NJ, 40 pages (1999).|
|4||"The Innovative Company Behind Rembrandt Products," product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet:14 pgs, (2004).|
|5||"Timoptic-XE® (Timolol Maleate Ophthalmic Gel Forming Solution)," product literature (instructions for use), Merck & Co., Inc., West Point, PA, issued Jun. 1999. 6 pgs.|
|6||"Ultradent Online Materials and Procedures Manual," [on-line]. Ultradent Products, Inc., 1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet ; 20 pgs.|
|7||"Discuss Dental product information sheets for Professional Whitening Products," [on-line]. Discuss Dental [retrieved on Mar. 13, 2000]. Retrieved from the Internet: <URL:http://www.discusdental.com/>;13 pgs.|
|8||"The Innovative Company Behind Rembrandt Products," product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet:<URL:http://www.rembrandt.com/denmat/about.htm>14 pgs, (2004).|
|9||"Ultradent Online Materials and Procedures Manual," [on-line]. Ultradent Products, Inc., 1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet <URL:http://www.ultradent.com/>; 20 pgs.|
|10||BASF Product Literature, "BASF Performance Chemicals Pluronic® & Tetronic® Surfactants," BASF Corporation (1996).|
|11||Den-Mat, product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet: ; 10 pgs.|
|12||Den-Mat, product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet: <URL:http://www.denmat.com/main/htm>; 10 pgs.|
|13||Haywood, et al., "Nightguard Vital Bleaching," Quintessence International, vol. 20, No. 3, pp. 173-176 (1989).|
|U.S. Classification||424/49, 424/53, 424/52, 106/35, 433/216, 433/215|
|International Classification||A61C5/00, A61Q11/00, A61K6/00, C09K13/06, A61K8/18, A61K8/00, A61K8/02, A61K8/22, A61K8/90|
|Cooperative Classification||A61K6/0017, A61K8/22, A61Q11/00, A61K8/02, A61K8/90|
|European Classification||A61K8/02, A61K6/00, A61K8/22, A61K8/90, A61Q11/00|
|Aug 8, 2011||REMI||Maintenance fee reminder mailed|
|Sep 25, 2011||FPAY||Fee payment|
Year of fee payment: 8
|Sep 25, 2011||SULP||Surcharge for late payment|
Year of fee payment: 7
|Jun 17, 2015||FPAY||Fee payment|
Year of fee payment: 12